Hourcade Dennis E
Washington University School of Medicine, Department of Medicine/Division of Rheumatology, St. Louis, MO 63110-1093, USA.
Curr Drug Targets. 2008 Feb;9(2):158-64. doi: 10.2174/138945008783502458.
The C3 convertases are the major proteases of the complement cascade and are assembled at the site of complement activation via several different pathways. Properdin's functional role in stabilizing the alternative pathway convertase has been long established; however, new evidence demonstrates that properdin can also bind to certain microbial surfaces, and provide a platform for de novo convertase assembly. Therefore, properdin participates in two distinct mechanisms for complement activation: the alternative pathway and a properdin-directed pathway. Previous work had implicated the alternative pathway in the initiation and/or progression of several autoimmune diseases and in the host defense against certain bacterial pathogens. Those conclusions were based on evidence that cannot distinguish effects of the alternative pathway from effects of the properdin-directed pathway. With the identification of the new role for properdin in C3 convertase assembly there became a pressing need to reassess the mechanisms of complement activation, determine the specific role of properdin in each of these pathways, and explore the new therapeutic avenues that could arise.
C3转化酶是补体级联反应的主要蛋白酶,可通过几种不同途径在补体激活部位组装。备解素在稳定替代途径转化酶方面的功能作用早已确立;然而,新证据表明备解素也可结合某些微生物表面,并为从头组装转化酶提供一个平台。因此,备解素参与补体激活的两种不同机制:替代途径和备解素导向途径。先前的研究表明替代途径与几种自身免疫性疾病的起始和/或进展以及宿主抵御某些细菌病原体有关。这些结论所依据的证据无法区分替代途径的作用与备解素导向途径的作用。随着备解素在C3转化酶组装中的新作用被发现,迫切需要重新评估补体激活机制,确定备解素在每条途径中的具体作用,并探索可能出现的新治疗途径。